Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Study shows gut microbiome changes may be effect, not cause, of autism spectrum disorders

Nov. 12, 2021

Roche patents potassium voltage-gated channel subfamily C member 1 activators

Nov. 12, 2021

SCO-spondin-derived peptide shows neuroprotection and increased synaptic transmission in the CNS

Nov. 12, 2021

BACH1 targeting has neuroprotective effects in Parkinson's disease

Nov. 11, 2021

Gain reports preclinical data on GT-02287 and GT-02329 for Gaucher's and GBA1 Parkinson's disease

Nov. 11, 2021

Virpax announces contracts to support development and manufacturing of Envelta

Nov. 11, 2021

MEF2 as key regulator and potential therapeutic target for neurodegeneration

Nov. 11, 2021

TQS-168 extends survival in mouse model of ALS

Nov. 11, 2021

SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors

Nov. 11, 2021

New NMDA receptor antagonists described by Suzhou Nhwa Biomedical Technology

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...